In this study, we found that SEC62 is overexpressed in ovarian cancer cells, SEC62 expression can serve as a prognostic marker for patients with ovarian cancer or borderline tumor of the ovary and SEC62 is a potential tumor-driver gene accounting for 3q amplification in ovarian cancer. This evidence concerns the gene SEC62 and ovarian carcinoma.